Uracil Arabinoside
Specifications
3083-77-0CAS Number
221-386-9EC Number
1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dioneIUPAC Name
C9H12N2O6Chemical Formula
244.2 g/molMolecular Weight
3083-77-0; Spongouridine; ARABINOFURANOSYLURACIL; Uracil arabinoside; Ara-U; Arabinosyluracil; NSC 68928; ZK0WMW5NQF; 2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-; DTXSID80184832; Uracil, 1-beta-D-arabinofuranosyl-; NSC-68928; Sponguridine; Arabinoside, Uracil; Ara U; Uracil Arabinofuranoside; Arabinofuranoside, Uracil; 1 beta D Arabinofuranosyl Uracil; 1-beta-D-Arabinofuranosyl Uracil; Uracil, 1-beta-D-Arabinofuranosyl; RefChem:559039; DTXCID20107323; 221-386-9; 1-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidine-2,4-dione; Arauridine; 1-beta-D-Arabinofuranosyluracil; 1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; Spongouridin; MFCD00065998; Uracil-beta-D-arabinofuranoside; Uracil 1-|A-D-arabinofuranoside; 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; Uridine arabinoside; 1-b-D-Arabinofuranosyluracil; Spongouridine (VAN); C9H12N2O6; 1beta-D-Arabinofuranosyluracil; 1-beta-D-Arabinofurnosyluracil; EINECS 221-386-9; BRN 0028749; 1-|A-D-Arabinofuranosyluracil; 1-beta-D-Arabinofuranosylpyrimidine-2,4(1H,3H)-dione (Uracil Arabinoside); Uracil, 1-.beta.-D-arabinofuranosyl-; DRTQHJPVMGBUCF-CCXZUQQUSA-N; Vidarabine Impurity 2; 1-beta-D-Arabinofuranosyl-(1H,3H)-pyrimidine-2,4-dione; Uracil arabinoside CRS; UNII-ZK0WMW5NQF; Uracil, 1-beta-D-arabinofuranosyl- (VAN); 1-eta--rabinofuranosyluracl; 1-?-D-Arabinofuranosyluracil; 5-24-06-00136 (Beilstein Handbook Reference); SCHEMBL359587; Uracil 1--D-arabinofuranoside; orb1220598; orb1301374; Uracil 1-b-D-arabinofuranoside; 1-(b-D-Arabinofuranosyl)uracil; CHEMBL1092065; CHEBI:68346; HY-N6652R; Uracil 1-??-D-arabinofuranoside; 1-(beta-D-arabinofuranosyl)uracil; 2,4(1H,3H)-Pyrimidinedione, 1-.beta.-D-arabinofuranosyl-; GLXC-07792; HY-N6652; URACIL ARABINOSIDE [USP-RS]; HG1013; s4807; AKOS015969693; CCG-266899; EBC-617422; NA05962; 1-| cent-D-ARABINOFURANOSYLURACIL; 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione; BP-43549; DS-14592; SY038117; 1-beta-D-Arabinofuranosyluracil (Standard); CS-0083204; NS00076410; SW220050-1; T5979; F214908; 1-(beta-D-arabinofuranosyl)-pyrimidin-2,4(3H)-dione; BRD-K32566431-001-01-4; Q27136843; 1-beta-D-Arabinofuranosyl-(1H3H)-pyrimidine-24-dione; 1-beta-D-Arabinofuranosylpyrimidine-2,4(1H,3H)-dione; 2,4(1H,3H)-Pyrimidinedione, 1-|A-D-arabinofuranosyl-; Uracil 1-beta-D-arabinofuranoside, lymphoma antiproliferative; 1-.BETA.-D-ARABINOFURANOSYL-2,4(1H,3H)-PYRIMIDINEDIONE; Uracil arabinoside, European Pharmacopoeia (EP) Reference Standard; Uracil arabinoside, United States Pharmacopeia (USP) Reference Standard; 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dioneSynonyms
